The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1420
July 8, 2013
View Complete Issue         Table of Contents 2019 
Quartette: An Ascending-Dose, Extended-Cycle Oral Contraceptive
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Quartette: An Ascending-Dose, Extended-Cycle Oral Contraceptive
July 8, 2013 (Issue: 1420)
The FDA has approved Quartette (Teva), an extended-cycle combination oral contraceptive containing increasing doses of the estrogen ethinyl estradiol (EE) combined with the progestin levonorgestrel (LNG). The rationale is that a gradual increase...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Quartette: An Ascending-Dose, Extended-Cycle Oral Contraceptive
Article code: 1420b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.